2-tert-butyl-5-isopropyl-1H-pyrrole | 1334326-69-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 2-tert-butyl-5-isopropyl-1H-pyrrole
• 英文别名: 2-tert-butyl-5-propan-2-yl-1H-pyrrole
• CAS: 1334326-69-0
• 化学式: C₁₁H₁₉N
• 分子量: 165.279
• InChiKey: LJZQFJBFLNLHBQ-UHFFFAOYSA-N

物化性质

• 沸点：
  227.4±9.0 °C(Predicted)
• 密度：
  0.895±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  15.8
• 氢给体数：
  1
• 氢受体数：
  0

反应信息

• 作为产物：
  描述：

  频哪酮 、 L-缬氨醇 在 dichlorobis(dicyclohexylphosphinomethylpyridine)-ruthenium (II) 、 potassium tert-butylate 作用下， 以 neat (no solvent) 为溶剂， 反应 24.0h， 以39%的产率得到2-tert-butyl-5-isopropyl-1H-pyrrole
  参考文献：
  名称：

  The Dual Role of Ruthenium and Alkali Base Catalysts in Enabling a Conceptually New Shortcut to N-Unsubstituted Pyrroles through Unmasked α-Amino Aldehydes

  摘要：

  A virtually salt-free and straightforward bimolecular assembly giving N-unsubstituted pyrroles through fully unmasked a-amino aldehydes, which was enabled by the dual effects of a catalytic ruthenium complex and an alkali metal base, is reported. Either solvent-free or acceptorless dehydrogenation facilitates high atom, step, and pot economy, which are otherwise difficult to achieve in multistep operations involving protection/deprotection.

  DOI：

  10.1021/ol4001262

文献信息

• METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY
  申请人：FOO Shi Yin

  公开号：US20120122844A1

  公开（公告）日：2012-05-17

  The present invention provides the use of a neutral endopeptidase inhibitor, in the manufacture of a medicament for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The invention also relates to the use of a compound of Formula I: wherein R 1 , R 2 , R 3 , R 5 , X, A 3 , B 1 , s and n are defined herein, for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of contrast-induced nephropathy.

  本发明提供了中性内切肽酶抑制剂的使用，用于制造用于治疗、改善和/或预防造影剂诱导性肾病的药物。该发明还涉及使用化合物Formula I中的化合物：其中R1、R2、R3、R5、X、A3、B1、s和n在此处定义，用于治疗、改善和/或预防造影剂诱导性肾病。本发明进一步提供了用于治疗、改善和/或预防造影剂诱导性肾病的药理活性剂的组合。
• PYRIDO[3,4-B]INDOLES AND METHODS OF USE
  申请人：Medivation Technologies, Inc.

  公开号：US20130190308A1

  公开（公告）日：2013-07-25

  This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[3,4-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.

  本公开涉及新的杂环化合物，可用于调节个体中的组胺受体。其中描述了吡啶并[3,4-b]吲哚，以及包含该化合物的药物组合物和使用该化合物进行各种治疗应用的方法，包括治疗认知障碍、精神障碍、神经递质介导的障碍和/或神经元障碍。
• PYRIDO[4,3-B]INDOLES AND METHODS OF USE
  申请人：MEDIVATION TECHNOLOGIES, INC.

  公开号：US20130190344A1

  公开（公告）日：2013-07-25

  This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[4,3-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.

  本公开涉及新的杂环化合物，可用于调节个体中的组胺受体。其中描述了吡啶并[4,3-b]吲哚，以及包含该化合物的药物组合物和使用该化合物进行各种治疗应用的方法，包括治疗认知障碍、精神病性障碍、神经递质介导的障碍和/或神经元障碍。
• Polycyclic pyridone derivative
  申请人：Shionogi & Co., Ltd.

  公开号：US11453669B2

  公开（公告）日：2022-09-27

  The present invention provides a compound represented by the following formula (I): wherein, ring A is a substituted or unsubstituted non-aromatic heterocycle; ring C is a benzene ring or the like; Q is a 5-membered aromatic heterocycle or the like; each R1 is independently halogen or the like; L is substituted or unsubstituted alkylene; R3 is substituted or unsubstituted alkyl or the like; R4 is hydrogen or the like; and n is an integer of 1 to 3.

  本发明提供了由下式（I）代表的化合物： 其中，环 A 是取代或未取代的非芳香杂环；环 C 是苯环或类似物；Q 是 5 元芳香杂环或类似物；每个 R1 独立地是卤素或类似物；L 是取代或未取代的亚烷基；R3 是取代或未取代的烷基或类似物；R4 是氢或类似物；n 是 1 至 3 的整数。
• RUTHENIUM COMPLEX AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING RUTHENIUM-CONTAINING THIN FILM
  申请人：Tosoh Corporation

  公开号：EP2930179B1

  公开（公告）日：2018-09-05